1.
Enzymatic Synthesis of Acyclovir-Saccharide Derivatives and Evaluation of Their Properties
酶促合成阿昔洛韦糖基衍生物及其性质研究
2.
Both research groups conclude that helicase-primase inhibitors are more potent than acyclovir and its derivatives.
无论研究小组断定旋-引抑制剂更烈性比阿昔洛韦及其衍生物.
3.
The Syntheses of One Novel Anti-viral Drug Famciclovir and Its Intermediate Derivatives;
一种新型抗病毒药物法昔洛韦及其中间体衍生物的合成
4.
Pharmacokinetics of acyclovir bioadhesive vaginal tablets in rats
阿昔洛韦生物黏附性阴道片在大鼠体内的药物动力学考察
5.
Study on the Synthesis and Application of D-Allose and Its Derivatives;
D-阿洛糖及衍生物的合成与应用研究
6.
Simultaneous and Rapid Determination of Aciclovir, Ganciclovir and Penciclovir in Plasma Using Solid-phase Extraction and High-performance Liquid Chromatography;
SPE-HPLC法同时快速测定血浆中更昔洛韦、阿昔洛韦和喷昔洛韦的浓度
7.
Comparison of Effects of Ganciclovir and Acyclovir on Adult Varicella
更昔洛韦和阿昔洛韦治疗成人水痘的疗效比较
8.
Therapeutic effects of ganciclovir and aciclovir on varicella
更昔洛韦与阿昔洛韦治疗水痘临床疗效分析
9.
Objective:To investigate the clinic response of genital herpes (GH) treated by acyclovir (ACV) and valacyclovir(VCV).
目的:观察阿昔洛韦与万乃洛韦治疗生殖器疱疹的临床疗效。
10.
Preparation and Quality Control of Aciclovir Inclusion Compound Hard Capsules
阿昔洛韦包合物硬胶囊的制备及质量控制
11.
Study on the Glycosyl Galactose Acyclovir Triparted Pre-drug Nanoparticle Delivery System
半乳糖化阿昔洛韦三节前药纳米给药系统的研究
12.
Curative Efficacy of Cobamamide Combined with Acyclovir for Herpes Zoster Complicating Diabetes in Aged Patients
腺苷钴胺联合阿昔洛韦治疗带状疱疹合并老年糖尿病的疗效评价
13.
A HPLC method was established for the determination of Aciclovir in Aciclovir urea cream.
建立阿昔洛韦尿素乳膏中阿昔洛韦含量的HPLC测定方法。
14.
Pharmacokinetics and bioequivalence of valaciclovir hydrochloride tablets
盐酸伐昔洛韦片的人体药动学及生物等效性
15.
Preparation and Mucoadhesive Property of Valaciclovir Bioadhesive Microspheres
伐昔洛韦生物黏附微球的制备与黏附性能研究
16.
Bioequivalence of Valaciclovir Capsules in Human
盐酸伐昔洛韦胶囊的人体生物等效性研究
17.
Experimental study on in-vitro sustain-release of medical biofibrin glue carrying Ganciclovir
医用生物蛋白胶携载更昔洛韦体外缓释研究
18.
In 153 cases of prevention research,88 were in GCV group and 65 in ACV group;
预防研究共153例，更昔洛韦组88例，阿昔洛韦组65例。